Public Market Listing
3692HKEX
Live quotes, historical charts, and market capitalization for Hansoh Pharmaceutical Group are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(15 total)
15Total Assets
0Approved
8Phase 3 / Filed
7Phase 1–2 / Early
11Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | EGFRSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 3 | TYK2Small molecule | Psoriatic ArthritisPsoriasis | |
| Phase 3 | Dopamine D2/D3 and serotonin 5-HT1A/5-HT2A receptors (multi-target)Small molecule | Schizophrenia | |
| Phase 3 | GLP-1/GIP receptor (dual)Peptide | Obesity | |
| Phase 3 | IL-23 p19Monoclonal antibody | Psoriasis | |
| Phase 3 | Erythropoietin receptor (EPO-R)Peptide | Chronic Kidney Disease | |
| Phase 3 | GLP-1 receptorPeptide | Type 2 Diabetes | |
| Phase 3 | —Small molecule | Chronic Hepatitis B | |
| Phase 2 | EGFRSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 2 | GABA-A receptorSmall molecule | Major Depressive Disorder | |
| Phase 2 | Angiotensin II receptor type 1 (AT1R) + Endothelin receptor type A (ETA)Small molecule | Chronic Kidney Disease | |
| Phase 2 | IL-23 receptorPeptide | Psoriasis | |
| Phase 1 | Undisclosed / early pipelineSmall molecule | Schizophrenia | |
| Phase 1 | PCSK9Small molecule | Atherosclerotic Cardiovascular Disease | |
| Phase 1 | Undisclosed / early pipelineSmall molecule | Hypertension |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.